Pharmacy

Eli Lilly scoops injectable manufacturing site from Nexus

Eli Lilly will acquire a Wisconsin-based injectable manufacturing facility from Nexus Pharmaceuticals, a drugmaker in Illinois.

By: Paige Twenter

Tuesday, April 23rd, 2024

The site in Pleasant Prairie, Wis., will expand Eli Lilly’s global injectable portfolio, the company said April 22. The facility is expected to begin production in late 2025.

Next Up in Pharmacy

FDA rejects cortisol modulator for hypertension

Corcept Therapeutics has received a complete response letter from the FDA for its new drug application for relacorilant, a treatment…

By: Ella Jeffries
Yesterday
FDA grants priority review to Alzheimer’s agitation drug

Axsome Therapeutics received FDA acceptance and priority review designation for its supplemental new drug application for AXS-05, a treatment for…

By: Ella Jeffries
Yesterday
10 hospitals, health systems seeking pharmacy leaders

The following hospitals and health systems have recently posted job listings for pharmacy leaders. Note: This is not an exhaustive…

By: Ella Jeffries
Yesterday

Comments are closed.

Why efficiency is becoming the new growth strategy for ambulatory care organizations

Next Up in Pharmacy

FDA rejects cortisol modulator for hypertension

FDA grants priority review to Alzheimer’s agitation drug

10 hospitals, health systems seeking pharmacy leaders

Join the 500,000+ healthcare executives who start their day with Becker’s